Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

Share Price is delayed by 15 minutes
Get Live Data
174.00    0.00 (0.00%)
Bid:
166.00
Ask:
182.00
Spread: 16.00 (9.639%)
Market Cap: £104.96m
JZCP Live PriceLast checked at - London Stock Exchange

Intraday Jz Capital Share Chart

Interim Management Statement

22 Jun 2010 07:00

RNS Number : 9918N
JZ Capital Partners Ltd
22 June 2010
 



JZ CAPITAL PARTNERS LIMITED

(Registration No. 48761)

 

Registered Office:

2ND FLOOR, REGENCY COURT, GLATEGNY ESPLANADE, ST. PETER PORT,

GUERNSEY, GY1 3NQ

___________________________

 

TELEPHONE: + 44 1481 720321

FACSIMILE: + 44 1481 716117

E-MAIL: JZCP@bfgl.com

 

 

Interim Management Statement

22 June 2010

 

JZ Capital Partners Limited (LSE:JZCP) ("JZCP" or the "Company"), a closed ended investment company incorporated in Guernsey whose corporate objective is to create a portfolio of investments in businesses primarily in the United States, announces its Interim Management Statement ("IMS") for the period from 1 March 2010 to 31 May 2010.

 

Since 28 February 2010, the date to which the last audited accounts were prepared, our NAV has increased 3.5%; however had we had not paid the dividend summarized below, the NAV would have increased 4.4%.

 

Recent Events

 

·; On 1 April 2010, JZCP paid a dividend of $0.065 for each Ordinary Share.

·; On 1 April 2010, JZCP made an investment of $4.0 million in New Vitality, a leader in the direct-to-consumer nutritional supplement and personal care product sector. We purchased $3.6 million of preferred stock and $0.4 million in common stock, which represents a 9.2% ownership stake in each security.

 

·; On 14 April 2010, JZCP received $15.6 million in proceeds in connection with the refinancing of Wound Care Solutions, LLC and Sechrist Industries, Inc.'s subordinated notes.

 

·; On 4 May 2010, JZCP made an investment of $5.2 million in Galson Laboratories, a full service provider of analytical air testing. The Company purchased $2.5 million of senior notes, $2.7 million of preferred stock and $40 thousand in common stock. The Company holds a 50.0% ownership stake in both the senior notes and preferred stock securities and a 38.0% ownership stake in the common stock security. In addition to the existing $0.4 million of preferred stock at this investment's holding company, these new securities create a $5.6 million investment in the testing services "vertical".

 

Business Update

 

We continue to be cautiously optimistic about both the US economy, and the resulting positive effects on M & A activity. We are seeing some loosening up in the credit markets, but they continue to be far from what we would call "normal". All that being said, we are actively pursuing a series of acquisitions in several of the business "verticals" we mentioned in our February Investment Adviser's Report; we hope to have some interesting acquisitions to announce over the next six months.

 

Our micro-cap portfolio continues to perform, with no defaults with any of our lenders. These business values - the engine of JZCP's future - have held up well over the past year and a half, despite the economic upheaval.

 

 

 

Net Asset Value

 

For the three months ended 31 May 2010, JZCP's NAV increased by $16.0 million or 3.5%.

 

 28/2/2010

 31/5/2010

Net Asset Value ($000's) (1)

$457,513

$473,534

Number of Ordinary Shares Outstanding (000's)

65,019

65,019

Net Asset Value per Ordinary Share ($)

$7.04

$7.28

Market Price per Share ($)

$4.16

$4.24

NAV to Market Price Discount

41%

42%

 

(1) Per JZCP Board.

 

Pro Forma Balance Sheet

 

Below is a summary of JZCP's balance sheet as of the relevant dates:

($000's)

 28/2/2010

 31/5/2010

Cash

$134,867

$137,853

Listed Equities

69,642

76,587

Bank Debt

35,589

39,983

Private Investments

289,444

288,853

Other Assets (1)

682

734

Total Assets

$530,224

$544,010

 - Liabilities

(1,312)

(1,089)

 - Zero Dividend Preferred Shares

(71,399)

(69,387)

Net Asset Value

$457,513

$473,534

 

(1) Includes accrued dividends on Listed Equities.

 

For the three months ended 31 May 2010, our listed equities increased 10.0%. Our listed bank debt, both first and second lien investments, increased by 12.3%. Our mezzanine investments decreased by 1.1%, which is due in part to a small repayment on one investment. Excluding this repayment, the mezzanine portfolio would have increased 0.8%. The micro-cap portfolio increased 0.4% during the three month period. Excluding the recent acquisitions and refinancing mentioned in the Recent Events section, the micro-cap portfolio would have increased 4.1%. Note that of the 20 mezzanine and micro-cap investments, 16 are current on their interest payments as of 31 May 2010. For two of the four investments that are not current, we elected to accumulate paid in kind interest instead of cash interest.

 

 

 

Portfolio

 

At 31 May 2010, the Company's investment assets consisted of 44 investments totaling $405.7 million broken out as follows:

 

Number of Investments

% of Portfolio Valuation

as of 31/5/2010

Micro-Cap Portfolio

 10

31.8%

Cash

25.4%

Mezzanine Investments

10

15.6%

Listed Equity

3

14.1%

Legacy Portfolio

11

5.7%

Bank Debt

10

7.4%

Total Investment Assets

44

100.0%

 

46.9% of the portfolio is invested in "liquid" assets, which consist of cash, listed equity, and listed debt. These asset classes are valued at third party listed prices. Cash was mainly deposited with HSBC historically, but now is mainly invested in US treasuries. The remaining 53.1% of the portfolio is invested in private investments in micro-caps or mezzanine investments. These investments are valued at fair value by the JZCP Board of Directors. Historically these investments had been valued at fair value by the Directors of JZCP half yearly; but they resolved as from 30 November 2009 to perform a valuation review quarterly. As a point of reference, the average purchase multiple of the micro-cap investments was 6.0x. The current average enterprise multiple used at 31 May 2010 was 5.9x. In addition, our micro-cap businesses continue to be leveraged at less than 1.3x trailing twelve months EBITDA.

 

At 31 May 2010, 48.9% of the JZCP investments were valued below cost, and 51.1% were valued at or in excess of cost.

 

The top ten investments as of 31 May 2010 were as follows:

 

($000's)

Asset Category

Original Cost

Valuation as of 31/5/2010

% of Portfolio Valuation

as of 31/5/2010

Safety Insurance Group, Inc.

Listed Equity

$6,816

$42,131

10.4%

 

Accutest Holdings, Inc.

Micro-cap

31,516

34,905

8.6%

 

TAL International Group, Inc.

Listed Equity

13,798

33,146

8.2%

 

Continental Cement Company, LLC

Mezzanine

20,660

28,135

6.9%

 

Dantom Systems, Inc.

Micro-cap

21,674

25,111

6.2%

 

BG Holdings, Inc.

Micro-cap

21,832

24,078

5.9%

 

Dental Services Group, Inc.

Micro-cap

19,854

23,161

5.7%

 

Wound Care Solutions, LLC

Micro-cap

38,858

21,119

5.2%

 

GHW Holdings, Inc.

Micro-cap

7,467

20,190

5.0%

 

Petco Animal Supplies, Inc.

Listed Debt / Mezzanine

19,443

19,931

4.9%

 

Top Ten Investments

$201,918

$271,907

67.0%

 

Remaining Investments

179,907

133,840

33.0%

 

Total Portfolio

$381,825

$405,747

100.0%

 

 

The portfolio is diversified across the following business sectors:

 

Number of Companies

% of Portfolio Valuation

as of 31/5/2010

Health Care Equipment & Services

7

24.0%

Support Services

11

22.2%

House, Leisure & Personal Goods

8

10.4%

Financial General

4

10.8%

Industrial Engineering

5

9.9%

Construction Materials

4

12.3%

Other

5

10.4%

Total Portfolio

44

100.0%

 

 About JZCP

JZCP is a closed ended investment company incorporated in Guernsey. The Company's corporate objective is to create a portfolio of investments in businesses primarily in the United States providing a superior overall return comprised of a current yield and significant capital appreciation. The Company's strategies include investments in micro-cap buyouts, mezzanine loans (sometimes with equity participations) and high yield securities, senior secured debt and second lien loans and other debt and equity opportunities. The Company's Ordinary Shares and Zero Dividend Preferred Shares are listed on the London Stock Exchange.

 

All Enquiries:

Butterfield Fulcrum Group (Guernsey) Limited

The Company Secretary

2nd Floor, Regency Court

Glategny Esplanade

St Peter Port

Guernsey

GY1 3NQ

Tel: 01481 720321

Fax: 01481 716117

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSPGUBGQUPUGMG
Date   Source Headline
22nd Jun 20263:21 pmPRNNet Asset Value(s)
12th Jun 20267:00 amPRNAnnual results for the year ended 28 February 2026
22nd May 20263:12 pmPRNNet Asset Value(s)
22nd Apr 20262:35 pmPRNNet Asset Value(s)
16th Apr 20267:00 amPRNDisposal of interest in Factor Energia
24th Mar 20266:29 pmPRNNet Asset Value(s)
26th Feb 20262:54 pmPRNRefinancing of Esperante
23rd Feb 20265:08 pmPRNNet Asset Value(s)
5th Feb 202611:25 amPRNNotification of Major Holdings
2nd Feb 20262:09 pmPRNNotification of Major Holdings
21st Jan 20264:54 pmPRNNet Asset Value(s)
13th Jan 20261:14 pmPRNNotification of Major Holdings
29th Dec 20259:02 amPRNNotification of Major Holdings
24th Dec 20259:29 amPRNPDMR Shareholding
22nd Dec 20254:55 pmPRNNet Asset Value(s)
15th Dec 20257:00 amPRNDisposal of interest in TierPoint
12th Dec 202511:57 amPRNChange in Director Responsibilities
21st Nov 20256:45 pmPRNNet Asset Value(s)
6th Nov 20257:00 amPRNInterim Results for the Period Ended 31 August 2025
22nd Oct 20251:09 pmPRNNet Asset Value(s)
22nd Sep 20255:38 pmPRNNet Asset Value(s)
4th Sep 20253:28 pmPRNAppointment of Senior Independent Director
4th Sep 20251:40 pmPRNResults of Annual General Meeting
21st Aug 20252:21 pmPRNNet Asset Value(s)
25th Jul 202511:30 amPRNNotice of Annual General Meeting
21st Jul 20253:08 pmPRNNet Asset Value(s)
20th Jun 20253:31 pmPRNNet Asset Value(s)
12th Jun 20257:00 amPRNAnnual results for the year ended 28 February 2025
21st May 20254:05 pmPRNNet Asset Value(s)
23rd Apr 20252:51 pmPRNNet Asset Value(s)
4th Apr 202511:45 amPRNDirector Dealing (Correction Notification)
24th Mar 202511:35 amPRNNet Asset Value(s)
20th Mar 202511:09 amPRNDirectors Dealing
18th Mar 20254:00 pmPRNDirector/PDMR Shareholding
18th Mar 20254:00 pmPRNDirector/PDMR Shareholding
18th Mar 20254:00 pmPRNDirector/PDMR Shareholding
14th Mar 20258:00 amPRNCompulsory Redemption of Shares and Total Voting Rights
26th Feb 20257:00 amPRNCompulsory Redemption of Shares
21st Feb 20254:34 pmPRNNet Asset Value(s)
21st Jan 20253:20 pmPRNNet Asset Value(s)
20th Dec 20244:45 pmPRNNet Asset Value(s)
21st Nov 20244:24 pmPRNNet Asset Value(s)
7th Nov 20247:00 amPRNInterim results for the period ended 31 August 2024
22nd Oct 20249:20 amPRNNet Asset Value(s)
23rd Sep 20243:25 pmPRNNet Asset Value(s)
21st Aug 20243:25 pmPRNNet Asset Value(s)
1st Aug 20248:48 amPRNPDMR Dealings
31st Jul 20249:26 amPRNPDMR Dealings
30th Jul 20245:38 pmPRNPDMR Dealings
30th Jul 20245:25 pmPRNPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.